Search results
Guide for Newly Diagnosed Diabetes: How to Make a Plan
Healthline· 2 weeks agoReceiving a diabetes diagnosis can feel overwhelming at first. Learning more about diabetes care — ...
Dow Jones Darling Merck Pops As Cancer 'Star' Drives Quarterly Beat
Investor's Business Daily· 2 weeks agoMerck's bread-and-butter cancer drug grew by double digits again in the first quarter.
Fred L. Goldenberg: Medicare 2025 starting to bloom
Traverse City Record-Eagle· 1 day agoOver the last few weeks, I’ve been involved in several meetings, both in-person and online, regarding anticipated changes to Medicare and supplemental programs ...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 2 weeks agoIn the hospital specialty portfolio, neuromuscular blockade medicine, Bridion...down 8% year over...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 2 weeks agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 2 weeks agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
20 Fastest Growing Health Tech Companies in the World
Insider Monkey via Yahoo Finance· 2 weeks agoIn this article, we will be taking a look at the 20 fastest growing health tech companies in the...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 4 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Healthcare and drugmaker groups seek to revive challenge to US drug-pricing law
Reuters· 5 days agoHealthcare and drug industry groups on Wednesday urged a U.S. appeals court to revive their...
Will Higher Keytruda Sales Drive Merck's Q1
Forbes· 2 weeks agoMerck (NYSE: MRK) will report its Q1 2024 results on Thursday, April 25. As usual, Keytruda will be the driving growth for Merck with quarterly sales...
